iSOFT Wins new e-Prescribing Deal at Harrogate NHS Trust

iSOFTHarrogate and District NHS Foundation Trust is the latest NHS trust to place an order with iSOFT, a CSC company, for its e-prescribing and medicines administration (ePMA) solution to improve medicines management and reduce the risk of drug-related mistakes.

The move is part of the trust's commitment to ensuring safe and effective care at the 367-bed Harrogate District Hospital. The ePMA solution will integrate with the trust's existing IT infrastructure including PAS, laboratory and eDischarge systems to further promote the timely and accurate sharing of medicines related information within the trust and with GPs.

"We are dedicated to making the safety of our patients and the quality of care our highest priority," said Andrew Alldred, Harrogate's director of pharmacy. "With the proliferation of new drugs, many with similar sounding names, prescribing has become a hugely complex task that is fraught with risk. Paper-based medicines systems can no longer be relied on to meet the demanding needs of a modern and clinically complex hospital environment."

"With research suggesting that at least ten percent of medication orders contain errors, costing the NHS in excess of £500 million a year, there has never been a greater need for ePMA solutions to help improve the timeliness, appropriateness and accuracy of the prescribing and administration of medicines," said Adrian Stevens, managing director of iSOFT's UK and Ireland business. "Our solution has been shown to greatly reduce adverse medication errors and improve the efficiency of healthcare services."

Harrogate is the fourth NHS trust to become an early adopter of iSOFT's ePMA solution after Pennine Acute, Stockport and Leicester. "Harrogate is a welcome addition to the early adopter programme," Stevens said. "The trust has already achieved an impressive range of meaningful clinical engagement and we are looking forward to continuing our strategic relationship to deliver real benefits for the trust’s staff and its patients."

iSOFT ePMA provides new opportunities to improve the communication of medicines related information between medical, nursing and clinical pharmacy teams. Advanced drug formulary management underpinned by clinical and workflow based decision support provides a highly effective environment to help improve a hospital's performance in relation to medicines. In-built reporting and data analysis tools provide executive and management visibility of performance to help proactively address areas of concern or promote good practice.

iSOFT ePMA is shown to halve adverse medication errors at hospitals in Australia and New Zealand. These errors can prolong a patient's stay, which in turn blocks hospital beds and increases costs.

Related news articles:

About CSC
CSC is a global leader in providing technology-enabled business solutions and services. Headquartered in Falls Church, Va., CSC has approximately 97,000 employees and reported revenue of $16.2 billion for the 12 months ended September 30, 2011.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Routine AI Assistance may Lead to Loss o…

The introduction of artificial intelligence (AI) to assist colonoscopies is linked to a reduction in the ability of endoscopists (health professionals who perform colonoscopies) to detect precancerous growths (adenomas) in...